Ironsides Asset Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ironsides Asset Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,550	Closed	-$476K	–	162
2016 Q2	$476K	Sell	5,550 -33	-0.6%	-$2.96K	0.15%	91
2016 Q1	$485K	Hold	5,583	–	–	0.12%	109
2015 Q4	$630K	Sell	5,583 -384	-6%	-$41.7K	0.17%	91
2015 Q3	$603K	Hold	5,967	–	–	0.17%	96
2015 Q2	$734K	Sell	5,967 -1,404	-19%	-$168K	0.21%	87
2015 Q1	$844K	Buy	7,371 +4,584	+164%	+$506K	0.23%	85
2014 Q4	$282K	Sell	2,787 -1,155	-29%	-$112K	0.08%	133
2014 Q3	$360K	Buy	+3,942	New	+$346K	0.1%	125

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Ironsides Asset Advisors's IBB Position: Q3 2016 in Review

Ironsides Asset Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 5,550 shares — an estimated $476K sold.

Ironsides Asset Advisors first reported a position in IBB in Q3 2014 and held it in 8 quarters. The position peaked at $844K in Q1 2015. 464 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

Ironsides Asset Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
Ironsides Asset Advisors sold 5,550 iShares Biotechnology ETF shares in Q3 2016, an estimated $476K.
Ironsides Asset Advisors first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 8 quarters.
Ironsides Asset Advisors's iShares Biotechnology ETF position peaked at $844K in Q1 2015.
464 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on Ironsides Asset Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.